Loading clinical trials...
Loading clinical trials...
The goal of this observational study is to describe a new disease condition of histiocytosis related to injecting drug use, its preconditions, symptoms, signs, findings, and prognosis in a detailed an...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Tampere University Hospital
Collaborators
NCT05915208 · Histiocytosis, Langerhans Cell Histiocytosis, and more
NCT05762640 · Haemophagocytic Lymphohistiocytosis
NCT04943198 · Histiocytosis
NCT07488728 · EBV-associated T/NK-cell Lymphoproliferative Diseases, Refractory/Relapsed EBV-related Hemophagocytic Lymphohistiocytosis, and more
NCT07339345 · Lymphohistiocytosis, Hemophagocytic
Tampere University Hospital
Tampere, Pirkanmaa
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions